Ding, Xiaoyan
Li, Xiaoxia
Jiang, Yanxia
Li, Yujun
Li, Hong
Shang, Lipeng
Feng, Guilin
Zhang, Huhu
Xu, Ziyuan
Yang, Lina
Li, Bing
Zhao, Robert Chunhua
Funding for this research was provided by:
Natural Science Foundation of Qingdao Municipality (23-2-1-128-zyyd-jch)
National Natural Science Foundation of China (81971324)
Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (2022-I2M-1-012)
Article History
Received: 18 January 2024
Accepted: 24 February 2024
First Online: 2 March 2024
Declarations
:
: The 126 human lung adenocarcinoma samples were collected and authorized by the Ethics Committee of the Affiliated Hospital of Qingdao University (QYFY WZLL 27991), and informed consent was acquired from all patients. The lung squamous carcinoma microarray detection and analysis procedures were carried out by Shanghai outdo Biotech Company, following the acquisition of prior patient consent and ethical approval from the Institutional Research Ethics Committee (SHYJS-CP-1904009). Animal handling and procedures were approved by Laboratory Animal Welfare Ethics Committee of Qingdao University (No. 20221117BALB/cnude2420221230061 and No. 20230515BALB/cnude2420230623062).
: The authors declare no competing interests.